Compounds > sq-11725
Page last updated: 2024-08-23

sq-11725 and Ventricular Fibrillation

sq-11725 has been researched along with Ventricular Fibrillation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briceno, DF; Di Biase, L; Ferrick, KJ; Fisher, JD; Gross, JN; Grushko, MJ; Haramati, LB; Kim, SG; Krumerman, A; Lupercio, F; Villablanca, PA1
Lucchesi, BR; Patterson, E2

Other Studies

3 other study(ies) available for sq-11725 and Ventricular Fibrillation

ArticleYear
Where Is the Lead?: An Unusual Progression of Lead Fracture.
    JACC. Clinical electrophysiology, 2017, Volume: 3, Issue:1

    Topics: Defibrillators, Implantable; Device Removal; Equipment Failure; Female; Humans; Jervell-Lange Nielsen Syndrome; Lung; Middle Aged; Nadolol; Pericardium; Tomography, X-Ray Computed; Treatment Outcome; Ventricular Fibrillation

2017
Antifibrillatory actions of nadolol.
    The Journal of pharmacology and experimental therapeutics, 1982, Volume: 223, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Death, Sudden; Dogs; Electric Stimulation; Male; Myocardial Infarction; Nadolol; Propanolamines; Tachycardia; Ventricular Fibrillation

1982
Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Pharmacology, 1984, Volume: 28, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Dose-Response Relationship, Drug; Heart Conduction System; Male; Nadolol; Propanolamines; Propranolol; Sotalol; Ventricular Fibrillation

1984